Triumph Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Triumph Capital Management's LLY Position: Q3 2026 in Review
Triumph Capital Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $392K and bringing the position to 3,370 shares worth $3.9M. The position accounts for 0.68% of the portfolio, ranked #33.
Triumph Capital Management first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. 1,633 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Triumph Capital Management held 3,370 shares of Eli Lilly worth $3.9M as of Q3 2026.
- Triumph Capital Management bought 332 Eli Lilly shares in Q3 2026, an estimated $392K.
- Eli Lilly made up 0.68% of Triumph Capital Management's portfolio in Q3 2026, its #33 holding.
- Triumph Capital Management first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
- 1,633 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.